<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 10 Mar 2026 10:41:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  6-K        Sanofi                    For: Mar 10</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Sanofi++++++++++++++++++++For%3A+Mar+10/26137436.html</link>
   <description>si-local-file:///var/storage/secattach/20260310/26137436.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Sanofi++++++++++++++++++++For%3A+Mar+10/26137436.html</guid>
   <pubDate>Tue, 10 Mar 2026 10:41:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Form  6-K        Sanofi                    For: Mar 10</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Sanofi++++++++++++++++++++For%3A+Mar+10/26137436.html</link>
   <description>si-local-file:///var/storage/secattach/20260310/26137436.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Sanofi++++++++++++++++++++For%3A+Mar+10/26137436.html</guid>
   <pubDate>Tue, 10 Mar 2026 10:41:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Form  6-K        Sanofi                    For: Mar 10</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Sanofi++++++++++++++++++++For%3A+Mar+10/26137436.html</link>
   <description>si-local-file:///var/storage/secattach/20260310/26137436.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Sanofi++++++++++++++++++++For%3A+Mar+10/26137436.html</guid>
   <pubDate>Tue, 10 Mar 2026 10:41:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release:  Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</link>
   <description>
&lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;i&gt;Sanofi’s Board of Directors proposes the appointment of Christel &lt;/i&gt;&lt;i&gt;Heydemann&lt;/i&gt;&lt;i&gt; as an independent director&lt;/i&gt; &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;&lt;b&gt;Paris,&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;March &lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;, 202&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;. The Board of Directors of Sanofi has decided to propose, at the next Annual General Meeting of shareholders scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director, as well as the renewal of the mandates of Christophe Babule and Jean-Paul Kress. &lt;/p&gt;  &lt;p align=&quot;justify&quot; style=&quot;padding-left:0px;&quot;&gt;Patrick Kron, independent director and Chairman of the Nomination, Governance and CSR Committee, will step down from the Board at the end of his term, which will expire at the upcoming Annual General Meeting on April 29. The Board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+%C2%A0Sanofi%E2%80%99s+Board+of+Directors+proposes+the+appointment+of+Christel+Heydemann+as+an+independent+director/26114001.html</guid>
   <pubDate>Thu, 05 Mar 2026 03:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22912955</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50207266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00333693</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00376079</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report</title>
   <link>http://www.streetinsider.com/Press+Releases/Press+Release%3A+Filing+of+an+amendment+to+the+French+%E2%80%9CDocument+d%E2%80%99Enregistrement+Universel%E2%80%9D+containing+the+Annual+Financial+Report/26109486.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;Paris, March 4, 2026&lt;/b&gt;. Sanofi announces today the filing of an amendment to its “Document d’Enregistrement Universel” containing its Annual Financial Report with the French market regulator Autorité des marchés financiers (AMF).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;This amendment notably includes additions to the report on corporate governance established in accordance with French law.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;This document is available on the company’s website:&lt;br/&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.sanofi.com/en/investors/reports-and-publications/financial-reports-and-regulated-information&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;https://www.sanofi.com/en/investors/reports-and-publications/financial-reports-and-regulated-information&lt;/a&gt; and on the website of the AMF (&lt;a target=&quot;_blank&quot; href=&quot;http://www.amf-france.org&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;www.amf-france.org&lt;/a&gt;). &lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;About Sanofi&lt;/i&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Press+Release%3A+Filing+of+an+amendment+to+the+French+%E2%80%9CDocument+d%E2%80%99Enregistrement+Universel%E2%80%9D+containing+the+Annual+Financial+Report/26109486.html</guid>
   <pubDate>Wed, 04 Mar 2026 12:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report</title>
   <link>http://www.streetinsider.com/Press+Releases/Press+Release%3A+Filing+of+an+amendment+to+the+French+%E2%80%9CDocument+d%E2%80%99Enregistrement+Universel%E2%80%9D+containing+the+Annual+Financial+Report/26109486.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;Paris, March 4, 2026&lt;/b&gt;. Sanofi announces today the filing of an amendment to its “Document d’Enregistrement Universel” containing its Annual Financial Report with the French market regulator Autorité des marchés financiers (AMF).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;This amendment notably includes additions to the report on corporate governance established in accordance with French law.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;This document is available on the company’s website:&lt;br/&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.sanofi.com/en/investors/reports-and-publications/financial-reports-and-regulated-information&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;https://www.sanofi.com/en/investors/reports-and-publications/financial-reports-and-regulated-information&lt;/a&gt; and on the website of the AMF (&lt;a target=&quot;_blank&quot; href=&quot;http://www.amf-france.org&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;www.amf-france.org&lt;/a&gt;). &lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;About Sanofi&lt;/i&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Press+Release%3A+Filing+of+an+amendment+to+the+French+%E2%80%9CDocument+d%E2%80%99Enregistrement+Universel%E2%80%9D+containing+the+Annual+Financial+Report/26109486.html</guid>
   <pubDate>Wed, 04 Mar 2026 12:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report</title>
   <link>http://www.streetinsider.com/Press+Releases/Press+Release%3A+Filing+of+an+amendment+to+the+French+%E2%80%9CDocument+d%E2%80%99Enregistrement+Universel%E2%80%9D+containing+the+Annual+Financial+Report/26109486.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;Paris, March 4, 2026&lt;/b&gt;. Sanofi announces today the filing of an amendment to its “Document d’Enregistrement Universel” containing its Annual Financial Report with the French market regulator Autorité des marchés financiers (AMF).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;This amendment notably includes additions to the report on corporate governance established in accordance with French law.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;This document is available on the company’s website:&lt;br/&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.sanofi.com/en/investors/reports-and-publications/financial-reports-and-regulated-information&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;https://www.sanofi.com/en/investors/reports-and-publications/financial-reports-and-regulated-information&lt;/a&gt; and on the website of the AMF (&lt;a target=&quot;_blank&quot; href=&quot;http://www.amf-france.org&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;www.amf-france.org&lt;/a&gt;). &lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;About Sanofi&lt;/i&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Press+Release%3A+Filing+of+an+amendment+to+the+French+%E2%80%9CDocument+d%E2%80%99Enregistrement+Universel%E2%80%9D+containing+the+Annual+Financial+Report/26109486.html</guid>
   <pubDate>Wed, 04 Mar 2026 12:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report</title>
   <link>http://www.streetinsider.com/Press+Releases/Press+Release%3A+Filing+of+an+amendment+to+the+French+%E2%80%9CDocument+d%E2%80%99Enregistrement+Universel%E2%80%9D+containing+the+Annual+Financial+Report/26109486.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;Paris, March 4, 2026&lt;/b&gt;. Sanofi announces today the filing of an amendment to its “Document d’Enregistrement Universel” containing its Annual Financial Report with the French market regulator Autorité des marchés financiers (AMF).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;This amendment notably includes additions to the report on corporate governance established in accordance with French law.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;This document is available on the company’s website:&lt;br/&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.sanofi.com/en/investors/reports-and-publications/financial-reports-and-regulated-information&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;https://www.sanofi.com/en/investors/reports-and-publications/financial-reports-and-regulated-information&lt;/a&gt; and on the website of the AMF (&lt;a target=&quot;_blank&quot; href=&quot;http://www.amf-france.org&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;www.amf-france.org&lt;/a&gt;). &lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;About Sanofi&lt;/i&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Press+Release%3A+Filing+of+an+amendment+to+the+French+%E2%80%9CDocument+d%E2%80%99Enregistrement+Universel%E2%80%9D+containing+the+Annual+Financial+Report/26109486.html</guid>
   <pubDate>Wed, 04 Mar 2026 12:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.22211465</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00356206</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54450828</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SAN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
 </channel>
</rss>
